Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000200406-25-000021
Filing Date
2025-02-12
Accepted
2025-02-12 18:07:01
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739401614.html 4  
1 FORM 4 wk-form4_1739401614.xml 4 4121
  Complete submission text file 0000200406-25-000021.txt   5537
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Swanson James D. (Reporting) CIK: 0001904785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 25616398